Beacon Biosignals’ Dreem 3S Headband Can Now Evolve Faster with FDA-Cleared Plan
The FDA authorizes Beacon Biosignals’ Predetermined Change Control Plan for the Dreem 3S EEG headband, enabling continuous algorithm updates to advance sleep monitoring and clinical-grade EEG analytics.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
